aspartic acid has been researched along with Liver Cirrhosis in 48 studies
Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent
L-aspartic acid : The L-enantiomer of aspartic acid.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Enzymatic analysis of aspartate/alanine aminotransferase (AST/ALT) does not exactly represent the progression of liver fibrosis or inflammation." | 7.96 | Immunological measurement of aspartate/alanine aminotransferase in predicting liver fibrosis and inflammation. ( Baik, GH; Bang, CS; Choi, EY; Ham, YL; Kim, DJ; Kim, HJ; Kim, SY; Shin, SP; Suk, KT; Yang, YJ, 2020) |
| "Enzymatic analysis of aspartate/alanine aminotransferase (AST/ALT) does not exactly represent the progression of liver fibrosis or inflammation." | 3.96 | Immunological measurement of aspartate/alanine aminotransferase in predicting liver fibrosis and inflammation. ( Baik, GH; Bang, CS; Choi, EY; Ham, YL; Kim, DJ; Kim, HJ; Kim, SY; Shin, SP; Suk, KT; Yang, YJ, 2020) |
| "Asymmetric dimethylarginine (ADMA) is an inhibitor of nitric oxide synthase that accumulates in liver disease and may contribute to hepatic encephalopathy (HE)." | 3.79 | Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosis. ( Ahluwalia, V; Bajaj, JS; Bouneva, I; Fuchs, M; Gilles, H; Heuman, DM; Kraft, KA; Luketic, V; Monteith, P; Noble, NA; Puri, P; Sanyal, AJ; Sterling, RK; Stravitz, RT; Wade, JB; White, MB, 2013) |
| " This study investigates the reversing capacity of an adenosine derivative compound (IFC305) on a rat model of liver cirrhosis and gene expression changes associated with it." | 3.76 | An adenosine derivative compound, IFC305, reverses fibrosis and alters gene expression in a pre-established CCl(4)-induced rat cirrhosis. ( de Sánchez, VC; Hernández-Luis, F; Hernández-Muñoz, R; Loredo, ML; Martínez-Pérez, L; Pérez-Carreón, JI; Ramírez-Salcedo, J; Suárez-Cuenca, JA; Velasco-Loyden, G; Velázquez-Martínez, I; Vidrio-Gómez, S; Yañez-Maldonado, L, 2010) |
| " Among a number of clinical and laboratory variables analyzed, the only independent predictive factors of overt HE were hyponatremia (serum sodium < 130 mEq / l), history of overt HE, serum bilirubin,and serum creatinine." | 3.75 | Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis. ( Arroyo, V; Baccaro, ME; Ginès, P; Gómez-Ansón, B; Guevara, M; Martín-Llahí, M; Monté-Rubio, GC; Rami, L; Ríos, J; Torre, A; Torres, F, 2009) |
| " Decreased myo-inositol and increased glutamine levels were noted to be the most sensitive spectroscopic markers for cirrhotic patients with hepatic encephalopathy (HE)." | 3.70 | Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve. ( Kim, ST; Lee, JH; Lee, YS; Lim, TH; Min, YI; Mun, CW; Seo, DW; Suh, DJ, 1999) |
| "Hereditary hemochromatosis is the most frequent hereditary metabolic disorder, with lethal outcome without treatment." | 2.42 | [Iron storage disease]. ( Dávid, K; Horváth, G, 2004) |
| "The enhanced liver fibrosis (ELF) index is a highly sensitive noninvasive marker of hepatic fibrosis that has had limited assessment in the HIV/HCV population." | 1.62 | The Enhanced Liver Fibrosis Index Predicts Hepatic Fibrosis Superior to FIB4 and APRI in HIV/HCV Infected Patients. ( Abdel-Hameed, EA; Kottilil, S; Rouster, SD; Sherman, KE, 2021) |
| "The prevalence of hepatotoxicity, liver fibrosis, and CKD were 7." | 1.51 | Evaluation of hepatic and kidney dysfunction among newly diagnosed HIV patients with viral hepatitis infection in Cape Coast, Ghana. ( Anabire, NG; Annan, I; Aryee, PA; Eliason, S; Hagan, OCK; Helegbe, GK; Luuse, AT; Obiri-Yaboah, D; Tetteh, WJ, 2019) |
| "Patients who have liver cirrhosis are at increased risk of bacterial infections, such as bacteremia, meningitis, pneumonia, urinary tract infections, and spontaneous bacterial peritonitis, due to immunodeficiency associated with the severity of the cirrhosis." | 1.34 | Brain abscess in adult cirrhotic patients: two case reports. ( Chen, IY; Chung, CL; Howng, SL; Kwan, AL; Lieu, AS, 2007) |
| "Minimal hepatic encephalopathy (MHE) is frequently diagnosed in patients with liver cirrhosis who do not show overt clinical cirrhosis-associated neurological deficits." | 1.33 | Chemical shift magnetic resonance spectroscopy of cingulate grey matter in patients with minimal hepatic encephalopathy. ( Graziadei, IW; Hinterhuber, H; Kugener, A; Marksteiner, J; Mattedi, M; Mechtcheriakov, S; Schocke, M; Vogel, W, 2005) |
| "The metabolic syndrome was present in 23 (27%), hepatic steatosis in 43 (50%), steatohepatitis in 18 (21%) and significant fibrosis in 38 (44%)." | 1.33 | The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis. ( Abraham, SC; Adams, LA; Angulo, P; Brandhagen, D; Torgerson, H, 2006) |
| "Hepatic encephalopathy is a common problem in cirrhosis." | 1.30 | Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. ( Andus, T; Feuerbach, S; Fründ, R; Geissler, A; Held, P; Hollerbach, S; Holstege, A; Lock, G; Schölmerich, J, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (41.67) | 18.7374 |
| 1990's | 4 (8.33) | 18.2507 |
| 2000's | 6 (12.50) | 29.6817 |
| 2010's | 8 (16.67) | 24.3611 |
| 2020's | 10 (20.83) | 2.80 |
| Authors | Studies |
|---|---|
| Jain, A | 1 |
| Sharma, BC | 1 |
| Mahajan, B | 1 |
| Srivastava, S | 1 |
| Kumar, A | 1 |
| Sachdeva, S | 1 |
| Sonika, U | 1 |
| Dalal, A | 1 |
| Ridola, L | 1 |
| Nardelli, S | 1 |
| Gioia, S | 1 |
| Faccioli, J | 1 |
| Riggio, O | 1 |
| Madian, A | 1 |
| Eliwa, A | 1 |
| Abdalla, H | 1 |
| A Azeem Aly, H | 1 |
| Kitsugi, K | 1 |
| Noritake, H | 1 |
| Matsumoto, M | 1 |
| Hanaoka, T | 1 |
| Umemura, M | 1 |
| Yamashita, M | 1 |
| Takatori, S | 1 |
| Ito, J | 1 |
| Ohta, K | 1 |
| Chida, T | 1 |
| Ulmasov, B | 1 |
| Neuschwander-Tetri, BA | 1 |
| Suda, T | 1 |
| Kawata, K | 1 |
| Pinto, L | 1 |
| Balbi, E | 1 |
| Halpern, M | 1 |
| Carius, L | 1 |
| Roma, J | 1 |
| Cardoso, SW | 1 |
| Grinsztejn, B | 1 |
| Veloso, VG | 1 |
| Pacheco, L | 1 |
| Perazzo, H | 1 |
| Sung, PS | 1 |
| Abdel-Hameed, EA | 1 |
| Rouster, SD | 1 |
| Kottilil, S | 1 |
| Sherman, KE | 1 |
| Gunda, DW | 1 |
| Mtui, EF | 1 |
| Manyiri, PM | 1 |
| Majinge, DC | 1 |
| Kilonzo, SB | 1 |
| Mazigo, HD | 1 |
| Kidenya, BR | 1 |
| Ding, Y | 1 |
| Lin, H | 1 |
| Chen, X | 1 |
| Zhu, B | 1 |
| Xu, X | 2 |
| Shen, W | 1 |
| Gao, M | 1 |
| He, N | 1 |
| Kim, HJ | 1 |
| Kim, SY | 1 |
| Shin, SP | 1 |
| Yang, YJ | 1 |
| Bang, CS | 1 |
| Baik, GH | 1 |
| Kim, DJ | 1 |
| Ham, YL | 1 |
| Choi, EY | 1 |
| Suk, KT | 1 |
| Anabire, NG | 1 |
| Tetteh, WJ | 1 |
| Obiri-Yaboah, D | 1 |
| Annan, I | 1 |
| Luuse, AT | 1 |
| Aryee, PA | 1 |
| Helegbe, GK | 1 |
| Hagan, OCK | 1 |
| Eliason, S | 1 |
| Rollet-Kurhajec, KC | 1 |
| Moodie, EE | 1 |
| Walmsley, S | 1 |
| Cooper, C | 1 |
| Pick, N | 1 |
| Klein, MB | 1 |
| Meng, LP | 1 |
| Chen, YC | 1 |
| Li, YH | 1 |
| Zhu, JS | 1 |
| Ye, JL | 1 |
| Guevara, M | 1 |
| Baccaro, ME | 1 |
| Torre, A | 1 |
| Gómez-Ansón, B | 1 |
| Ríos, J | 1 |
| Torres, F | 1 |
| Rami, L | 1 |
| Monté-Rubio, GC | 1 |
| Martín-Llahí, M | 1 |
| Arroyo, V | 1 |
| Ginès, P | 1 |
| Pérez-Carreón, JI | 1 |
| Martínez-Pérez, L | 1 |
| Loredo, ML | 1 |
| Yañez-Maldonado, L | 1 |
| Velasco-Loyden, G | 1 |
| Vidrio-Gómez, S | 1 |
| Ramírez-Salcedo, J | 1 |
| Hernández-Luis, F | 1 |
| Velázquez-Martínez, I | 1 |
| Suárez-Cuenca, JA | 1 |
| Hernández-Muñoz, R | 1 |
| de Sánchez, VC | 1 |
| Castera, L | 1 |
| Pinzani, M | 1 |
| Garcia-Martinez, R | 1 |
| Rovira, A | 1 |
| Alonso, J | 1 |
| Jacas, C | 1 |
| Simón-Talero, M | 1 |
| Chavarria, L | 1 |
| Vargas, V | 1 |
| Córdoba, J | 1 |
| Ferraioli, G | 1 |
| Tinelli, C | 1 |
| Malfitano, A | 1 |
| Dal Bello, B | 1 |
| Filice, G | 1 |
| Filice, C | 1 |
| Above, E | 1 |
| Barbarini, G | 1 |
| Brunetti, E | 1 |
| Calderon, W | 1 |
| Di Gregorio, M | 1 |
| Lissandrin, R | 1 |
| Ludovisi, S | 1 |
| Maiocchi, L | 1 |
| Michelone, G | 1 |
| Mondelli, M | 1 |
| Patruno, SF | 1 |
| Perretti, A | 1 |
| Poma, G | 1 |
| Sacchi, P | 1 |
| Zaramella, M | 1 |
| Zicchetti, M | 1 |
| Bajaj, JS | 1 |
| Ahluwalia, V | 1 |
| Wade, JB | 1 |
| Sanyal, AJ | 1 |
| White, MB | 1 |
| Noble, NA | 1 |
| Monteith, P | 1 |
| Fuchs, M | 1 |
| Sterling, RK | 1 |
| Luketic, V | 1 |
| Bouneva, I | 1 |
| Stravitz, RT | 1 |
| Puri, P | 1 |
| Kraft, KA | 1 |
| Gilles, H | 1 |
| Heuman, DM | 1 |
| FODOR, O | 2 |
| BORDA, M | 1 |
| MANASIA, M | 1 |
| SANTAY, I | 1 |
| LABORIE, G | 1 |
| KATSU, M | 1 |
| OGAWA, J | 1 |
| NAKAGAWA, H | 1 |
| OSAKO, R | 1 |
| ABE, T | 1 |
| YAMAMOTO, I | 1 |
| FAGE, P | 1 |
| KNAUFF, HG | 1 |
| SEYBOLD, D | 1 |
| KANTERS, A | 1 |
| Shindo, M | 1 |
| Hamada, K | 1 |
| Nishioji, K | 1 |
| Muramatsu, A | 1 |
| Oda, Y | 1 |
| Okuno, T | 1 |
| Horváth, G | 1 |
| Dávid, K | 1 |
| Mechtcheriakov, S | 1 |
| Schocke, M | 1 |
| Kugener, A | 1 |
| Graziadei, IW | 1 |
| Mattedi, M | 1 |
| Hinterhuber, H | 1 |
| Vogel, W | 1 |
| Marksteiner, J | 1 |
| Adams, LA | 1 |
| Angulo, P | 1 |
| Abraham, SC | 1 |
| Torgerson, H | 1 |
| Brandhagen, D | 1 |
| Chung, CL | 1 |
| Lieu, AS | 1 |
| Chen, IY | 1 |
| Kwan, AL | 1 |
| Howng, SL | 1 |
| De Luca, FM | 1 |
| Tuveri, A | 1 |
| Geissler, A | 1 |
| Lock, G | 1 |
| Fründ, R | 1 |
| Held, P | 1 |
| Hollerbach, S | 1 |
| Andus, T | 1 |
| Schölmerich, J | 1 |
| Feuerbach, S | 1 |
| Holstege, A | 1 |
| Iwamoto, H | 1 |
| Sakai, H | 1 |
| Kotoh, K | 1 |
| Nakamuta, M | 1 |
| Nawata, H | 1 |
| Lee, JH | 1 |
| Seo, DW | 1 |
| Lee, YS | 1 |
| Kim, ST | 1 |
| Mun, CW | 1 |
| Lim, TH | 1 |
| Min, YI | 1 |
| Suh, DJ | 1 |
| Schmidt, W | 1 |
| Wolf, G | 1 |
| Grüngreiff, K | 1 |
| Meier, M | 1 |
| Reum, T | 1 |
| Lavoie, J | 1 |
| Giguère, JF | 1 |
| Layrargues, GP | 1 |
| Butterworth, RF | 1 |
| Van Leuven, F | 1 |
| Weyne, J | 1 |
| Iencica, R | 1 |
| Busuttil, A | 1 |
| Alston, WC | 1 |
| Horne, CH | 1 |
| MacSween, RN | 1 |
| Leonhardt, H | 1 |
| Wotzka, R | 2 |
| Weber, D | 2 |
| Melzer, H | 1 |
| Szám, I | 1 |
| Müting, D | 1 |
| Popescu, S | 1 |
| Grigoraş, D | 1 |
| Barbarino, F | 1 |
| Aschke, J | 1 |
| Gumucio, JJ | 1 |
| Laughrey, EG | 1 |
| Henley, KS | 1 |
| Kosozu, K | 1 |
| Cachin, M | 1 |
| Pergola, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Role of Magnetic Resonance Imaging in Detection of Minimal Hepatic Encephalopathy[NCT04131205] | 40 participants (Anticipated) | Observational | 2019-06-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for aspartic acid and Liver Cirrhosis
| Article | Year |
|---|---|
[Iron storage disease].
Topics: Aspartic Acid; Carcinoma, Hepatocellular; Chromosomes, Human, Pair 6; Cysteine; Diabetes Mellitus; D | 2004 |
2 trials available for aspartic acid and Liver Cirrhosis
| Article | Year |
|---|---|
L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial.
Topics: Ammonia; Aspartic Acid; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Ornithine; Rifax | 2022 |
[On the therapy of liver diseases with ornithine aspartate].
Topics: Acute Disease; Alanine Transaminase; Ammonia; Aspartic Acid; Bilirubin; Cholangitis; Chronic Disease | 1969 |
45 other studies available for aspartic acid and Liver Cirrhosis
| Article | Year |
|---|---|
Letter to the editor: Episodic-precipitant-induced hepatic encephalopathy treatment: Look at new and old precipitants!
Topics: Aspartic Acid; Double-Blind Method; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Ornithine | 2022 |
Aspartate transferase-to-platelet ratio index-plus: A new simplified model for predicting the risk of mortality among patients with COVID-19.
Topics: Adult; Aspartate Aminotransferases; Aspartic Acid; Biomarkers; Blood Platelets; Cohort Studies; COVI | 2022 |
Arg-Gly-Asp-binding integrins activate hepatic stellate cells via the hippo signaling pathway.
Topics: Arginine; Aspartic Acid; Focal Adhesion Protein-Tyrosine Kinases; Glycine; Hepatic Stellate Cells; H | 2022 |
Effectiveness of Direct-acting Agents After Liver Transplantation A Real-life Study in Rio de Janeiro.
Topics: Antiviral Agents; Aspartic Acid; Biomarkers; Brazil; Carcinoma, Hepatocellular; Female; Hepacivirus; | 2022 |
A different detection method reveals a new role of alanine aminotransferase as an indicator of liver fibrosis.
Topics: Alanine; Alanine Transaminase; Aspartate Aminotransferases; Aspartic Acid; Humans; Inflammation; Liv | 2020 |
The Enhanced Liver Fibrosis Index Predicts Hepatic Fibrosis Superior to FIB4 and APRI in HIV/HCV Infected Patients.
Topics: Aspartate Aminotransferases; Aspartic Acid; Biomarkers; Hepacivirus; Hepatitis C; Hepatitis C, Chron | 2021 |
Schistosoma mansoni-related periportal fibrosis; can we use APRI and PSDR levels in the real-time selection of patients for targeted endoscopy in a resource-limited setting? A case-control study.
Topics: Animals; Aspartic Acid; Case-Control Studies; Cross-Sectional Studies; Endoscopy; Esophageal and Gas | 2021 |
Comprehensive metabolomics profiling reveals common metabolic alterations underlying the four major non-communicable diseases in treated HIV infection.
Topics: Adolescent; Adult; Aged; Alanine; Aspartic Acid; Atherosclerosis; Cognitive Dysfunction; Female; Glu | 2021 |
Immunological measurement of aspartate/alanine aminotransferase in predicting liver fibrosis and inflammation.
Topics: Alanine; Alanine Transaminase; Aspartate Aminotransferases; Aspartic Acid; Biomarkers; Biopsy; Hepat | 2020 |
Evaluation of hepatic and kidney dysfunction among newly diagnosed HIV patients with viral hepatitis infection in Cape Coast, Ghana.
Topics: Adult; Alanine Transaminase; Aspartic Acid; Blood Platelets; Coinfection; Cross-Sectional Studies; F | 2019 |
Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
Topics: Adult; Antiretroviral Therapy, Highly Active; Aspartate Aminotransferases; Aspartic Acid; Biomarkers | 2015 |
Viability assessment of magnetic resonance spectroscopy for the detection of minimal hepatic encephalopathy severity.
Topics: Adult; Aspartic Acid; Basal Ganglia; Brain; Cognition; Creatine; Female; Glutamic Acid; Glutamine; G | 2015 |
Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.
Topics: Adult; Aged; Aspartic Acid; Bilirubin; Brain Chemistry; Creatine; Creatinine; Female; Follow-Up Stud | 2009 |
An adenosine derivative compound, IFC305, reverses fibrosis and alters gene expression in a pre-established CCl(4)-induced rat cirrhosis.
Topics: Adenosine; Animals; Aspartic Acid; Carbon Tetrachloride; Gene Expression Profiling; Gene Expression | 2010 |
Non-invasive assessment of liver fibrosis: are we ready?
Topics: Aspartic Acid; Biomarkers; Elasticity Imaging Techniques; Humans; Liver Cirrhosis; Platelet Count | 2010 |
Hepatic encephalopathy is associated with posttransplant cognitive function and brain volume.
Topics: Adult; Aspartic Acid; Atrophy; Brain; Chi-Square Distribution; Cognition; Cognition Disorders; Femal | 2011 |
Performance of real-time strain elastography, transient elastography, and aspartate-to-platelet ratio index in the assessment of fibrosis in chronic hepatitis C.
Topics: Adult; Area Under Curve; Aspartic Acid; Biopsy; Blood Platelets; Disease Progression; Elasticity Ima | 2012 |
Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosis.
Topics: Adult; Arginine; Aspartic Acid; Biomarkers; Brain; Cognition Disorders; Cross-Sectional Studies; Fem | 2013 |
[Research on the ammonium-binding action of aspartic acid in hepatic diseases].
Topics: Ammonia; Ammonium Compounds; Aspartic Acid; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Liver D | 1960 |
[APROPOS OF THE CLINICAL INDICATIONS OF A NEW DRINKABLE ENRICHED LIVER EXTRACT OF THE ANTITOXIC FRACTION].
Topics: Alcoholic Intoxication; Alcoholism; Anemia; Aspartic Acid; Asthenia; Humans; Liver Cirrhosis; Liver | 1964 |
[CLINICAL TRIAL OF POTASSIUM AND MAGNESIUM SALTS OF ASPARTIC ACID IN LIVER DISEASES].
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Aspartic Acid; Geriatrics; Hepatitis; | 1964 |
[CLINICAL TRIALS OF A DRUG COMBINATION GROUPING THE ANTITOXIC FRACTIONS OF THE LIVER WITH ASPARTATES AND EXTRACTS OF THE LIVER WITH YEASTS].
Topics: Arteritis; Aspartic Acid; Drug Combinations; Geriatrics; Hernia, Diaphragmatic; Hernia, Hiatal; Huma | 1964 |
[FREE PLASMA AMINO ACIDS AND BLOOD AMMONIA FOLLOWING ORAL PROTEIN LOAD. STUDIES IN NORMAL PERSONS AND PATIENTS WITH LIVER CIRRHOSIS].
Topics: Amino Acids; Ammonia; Arginine; Aspartic Acid; Blood; Dietary Proteins; Glutamates; Humans; Liver Ci | 1965 |
The predictive value of liver fibrosis in determining the effectiveness of interferon and lamivudine therapies for chronic hepatitis B.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Aspartic Acid; DNA, Viral; Drug Resistance, Viral; Fe | 2004 |
Chemical shift magnetic resonance spectroscopy of cingulate grey matter in patients with minimal hepatic encephalopathy.
Topics: Aspartic Acid; Cerebral Cortex; Choline; Creatinine; Female; Glutamic Acid; Glutamine; Gyrus Cinguli | 2005 |
The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
Topics: Adult; Aged; Aspartic Acid; Cysteine; Fatty Liver; Female; Genetic Predisposition to Disease; Glucos | 2006 |
Brain abscess in adult cirrhotic patients: two case reports.
Topics: Aged; Aspartic Acid; Brain Abscess; Choline; Creatine; Humans; Liver Cirrhosis; Magnetic Resonance I | 2007 |
[Changes induced by intravenous administration of potassium salts in the electrocardiogram and in urinary excretion and plasmatic and erythrocytic levels of sodium and potassium].
Topics: Adult; Aged; Aspartic Acid; Chlorides; Diuresis; Electrocardiography; Electrolytes; Female; Glucose; | 1966 |
Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging.
Topics: Adult; Aged; Aspartic Acid; Brain; Choline; Female; Glutamic Acid; Hepatic Encephalopathy; Humans; I | 1997 |
Soluble Arg-Gly-Asp peptides reduce collagen accumulation in cultured rat hepatic stellate cells.
Topics: Animals; Arginine; Aspartic Acid; Cell Adhesion; Cells, Cultured; Collagen; Collagenases; Extracellu | 1999 |
Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve.
Topics: Adult; Aged; Aspartic Acid; Basal Ganglia; Brain; Choline; Creatinine; Energy Metabolism; Female; Gl | 1999 |
Hepatic encephalopathy influences high-affinity uptake of transmitter glutamate and aspartate into the hippocampal formation.
Topics: Adult; Aged; Aged, 80 and over; Ammonia; Animals; Aspartic Acid; Female; Glutamates; Glutamic Acid; | 1990 |
Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.
Topics: Aged; Amino Acids; Aspartic Acid; Brain Chemistry; Chromatography, High Pressure Liquid; Female; gam | 1987 |
Proceedings: Ammonia and amino acids in the brain of the rat with chronic hepatic failure.
Topics: Amino Acids; Ammonia; Animals; Aspartic Acid; Brain; Carbon Tetrachloride Poisoning; Chronic Disease | 1974 |
[Effects of treatment with nucleotides and aspartic acid in chronic liver diseases].
Topics: Aspartic Acid; Bilirubin; Chronic Disease; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Nucle | 1972 |
Effect of the production of experimental cirrhosis in rats on serum aminotransferase levels.
Topics: Alanine; Animals; Aspartic Acid; Carbon Tetrachloride; Drug Synergism; Kinetics; Liver Cirrhosis; Ph | 1972 |
[Pathogenesis and therapy of exogenous hepatic coma].
Topics: Amino Acids; Aspartic Acid; Brain; Dipeptides; Electroencephalography; Hepatic Encephalopathy; Human | 1973 |
[Further clinical experiences with ornithine aspartate in liver diseases].
Topics: Adult; Aspartic Acid; Fatty Liver; Female; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Male; | 1972 |
[Prevention and therapy of hepatic coma].
Topics: Aged; Amides; Ammonia; Aspartic Acid; Chlorothiazide; Clopamide; Depression, Chemical; Diuretics; Fe | 1970 |
[Treatment of hepatic cirrhosis and hepatic coma with drugs having the capacity of lowering the blood ammonia levels].
Topics: Ammonia; Arginine; Aspartic Acid; Bacteria; Female; Glutamates; Hepatic Encephalopathy; Humans; Live | 1967 |
[Treatment with aspartic acid in hepatic coma caused by hyperammonemia].
Topics: Ammonia; Aspartic Acid; Hepatic Encephalopathy; Humans; Liver Cirrhosis | 1968 |
[Experiences with ornithine-aspartate in liver diseases].
Topics: Adolescent; Adult; Aged; Aspartic Acid; Child; Female; Hepatitis A; Humans; Liver Cirrhosis; Liver D | 1969 |
Effect of hypokalemia on the reductive amination of alpha-ketoglutarate by mitochondria from normal and cirrhotic rat liver.
Topics: Ammonia; Animals; Aspartic Acid; Glutamate Dehydrogenase; Glutamates; Hypokalemia; Ketoglutaric Acid | 1969 |
[Clinical study on the effects of L-ornithine-L-aspartate on liver dysfunction].
Topics: Aspartic Acid; Hepatitis; Hepatitis B; Humans; Liver Cirrhosis; Ornithine | 1966 |
[Betaine aspartate in the hepato-digestive domain].
Topics: Aspartic Acid; Betaine; Dyspepsia; Fatty Liver; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; | 1966 |